Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In plain language, the medication makes alcohol less enjoyable at a neurochemical level
1 Guidelines, manufacturers, and FDA warnings have erred on the side of caution and recommend careful use of GLP-1 RAs in patients with a history or high risk of pancreatitis
16 participants (7 placebo, 9 semaglutide) elected not to consume at the post-treatment laboratory session Findings: These findings provide initial prospective evidence that low-dose semaglutide can reduce craving and some drinking outcomes, justifying larger clinical trials to evaluate GLP-1RAS for alcohol use disorder
They will also consider if the patient is taking other medications that could interact with either drug
K., Wang, Y.-Y
US$ 22.23
US$ 20.33
US$ 24.35
US$ 23.10
